Abstract: Clenbuterol or its salt for use in the treatment of autism, in particular pediatric autism. Improved contact with surroundings, better concentration, improved ability to plan a specific task, improved understanding, calming, and reduced psychomotor anxiety were observed.
Type:
Grant
Filed:
May 30, 2012
Date of Patent:
June 14, 2016
Assignees:
STOWARZYSZENIE SW. CELESTYNA, KRYSTYNA KOBEL-BUYS
Abstract: Clenbuterol or its salt for use in the treatment of autism, in particular pediatric autism. Improved contact with surroundings, better concentration, improved ability to plan a specific task, improved understanding, calming, and reduced psychomotor anxiety were observed.